Land: Canada
Taal: Engels
Bron: Health Canada
ARIPIPRAZOLE
PHARMASCIENCE INC
N05AX12
ARIPIPRAZOLE
15MG
TABLET
ARIPIPRAZOLE 15MG
ORAL
30
Prescription
ATYPICAL ANTIPSYCHOTICS
Active ingredient group (AIG) number: 0152514003; AHFS:
APPROVED
2018-07-10
PRODUCT MONOGRAPH INCLUDING PATIENT MEDICATION INFORMATION PR PMS-ARIPIPRAZOLE Aripiprazole Tablets Tablets, 2 mg, 5 mg, 10 mg, 15 mg, 20 mg and 30 mg, Oral House Standard Antipsychotic Agent PHARMASCIENCE INC. 6111 Royalmount Ave., Suite 100 Montréal, Canada H4P 2T4 www.pharmascience.com DATE OF INITIAL AUTHORIZATION JUL 10, 2018 DATE OF REVISION: OCT 17, 2022 Submission Control No: 264122 _pms-ARIPIPRAZOLE Product Monograph _ _Page 2 of 70_ RECENT MAJOR LABEL CHANGES 7 WARNINGS AND PRECAUTIONS, Skin 11/2022 TABLE OF CONTENTS RECENT MAJOR LABEL CHANGES ............................................................................................. 2 TABLE OF CONTENTS ............................................................................................................... 2 PART I: HEALTH PROFESSIONAL INFORMATION ....................................................................... 4 1 INDICATIONS ..................................................................................................................... 4 1.1 Pediatric ................................................................................................................. 4 1.2 Geriatrics ................................................................................................................ 4 2 CONTRAINDICATIONS ........................................................................................................ 5 3 SERIOUS WARNINGS AND PRECAUTIONS BOX ................................................................... 5 4 DOSAGE AND ADMINISTRATION ........................................................................................ 5 4.1 Dosing Considerations ............................................................................................. 5 4.2 Recommended Dose and Dosage Adjustment .......................................................... 6 4.3 Administration ........................................................................................................ 7 4.4 Reconstitution.......................... Lees het volledige document